Association of pneumococcal conjugate vaccination with SARS-CoV-2 infection among older adult recipients of COVID-19 vaccines: a longitudinal cohort study.

Joseph A LewnardVennis HongLindsay R GrantBradley K AckersonKatia J BruxvoortMagdalena PomichowskiAdriano ArguedasAlejandro CanéLuis JodarBradford D GessnerSara Y Tartof

Published in: The Journal of infectious diseases (2024)

Among older adults who had received ≥2 COVID-19 vaccine doses, PCV13 was associated with modest protection against SARS-CoV-2 infection. Protective effects of PCV13 were greater among individuals expected to have weaker immune protection against SARS-CoV-2 infection.

Keyphrases

respiratory syndrome coronavirus
coronavirus disease
sars cov
cancer therapy
kidney transplantation
young adults